TORONTO, March 30 /CNW/ - Bayer Inc. (Bayer), in consultation with Health
Canada, has informed health care professionals of new safety information
regarding the drug Trasylol(R) (aprotinin). Trasylol(R) is a drug injected
during heart bypass surgery to help reduce bleeding and the need for blood
transfusions.
